ArticlePharmaceutical medicine2024

Evaluation of the Effectiveness of Additional Risk Minimization Measures for Ixazomib Citrate for Relapsed/Refractory Multiple Myeloma in Japan: A Web-Based Survey Among Pharmacists.

Yoshiko Maeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.